Publications

The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence.

Movahedzadeh, F; Smith, DA; Norman, RA; Dinadayala, P; Murray-Rust, J; Russell, DG; Kendall, SL; Rison, SC G; McAlister, MS B; BANCROFT, GJ; McDonald, NQ; Daffe, M; Av-Gay, Y; Stoker, NG;

2003

Molecular microbiology, (2003).51 4 10.1046/j.1365-2958.2003.03900.x.

Mycobacterium tuberculosis Beijing genotype.

Lillebaek, T; Andersen, AB; Dirksen, A; GLYNN, JR; Kremer, K;

2003

Emerging infectious diseases, (2003).9 12 10.3201/eid0912.030276.

Tuberculosis in travellers.

JOHNSTON, VJ; GRANT, AD;

2003

Travel medicine and infectious disease, (2003).1 4 10.1016/j.tmaid.2003.11.002.

Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.

Weir, RE; FINE, PE M; Nazareth, B; FLOYD, S; Black, GF; KING, E; Stanley, C; Bliss, L; BRANSON, K; DOCKRELL, HM;

2003

Clinical and experimental immunology, (2003).134 2 10.1046/j.1365-2249.2003.02272.

Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB.

CORBETT, EL; Charalambous, S; FIELDING, K; CLAYTON, T; HAYES, RJ; De Cock, KM; Churchyard, GJ;

2003

The Journal of infectious diseases, (2003).188 8 10.1086/378519.

Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa.

Campbell, SJ; Sabeti, P; FIELDING, K; Sillah, J; Bah, B; Gustafson, P; Manneh, K; Lisse, I; Sirugo, G; Bellamy, R; Bennett, S; Aaby, P; McAdam, KP W J; Bah-Sow, O; Lienhardt, C; Hill, AV S;

2003

Immunogenetics, (2003).55 7 10.1007/s00251-003-0602-9.

Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection.

Lillebaek, T; Dirksen, A; VYNNYCKY, E; Baess, I; Thomsen, VØ; Andersen, AB;

2003

The Journal of infectious diseases, (2003).188 7 10.1086/378240.

Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?.

Churchyard, GJ; FIELDING, K; Charalambous, S; Day, JH; CORBETT, EL; HAYES, RJ; Chaisson, RE; De Cock, KM; Samb, B; GRANT, AD;

2003

AIDS (London, England), (2003).17 14 10.1097/00002030-200309260-00007.

Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis.

Hinchliffe, SJ; Isherwood, KE; STABLER, RA; Prentice, MB; Rakin, A; Nichols, RA; Oyston, PC F; Hinds, J; Titball, RW; WREN, BW;

2003

Genome research, (2003).13 9 10.1101/gr.1507303.

Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia.

Lienhardt, C; FIELDING, K; Sillah, J; Tunkara, A; Donkor, S; Manneh, K; Warndorff, D; McAdam, KP; Bennett, S;

2003

American journal of respiratory and critical care medicine, (2003).168 4 10.1164/rccm.200212-1483OC.